Influence of istradefylline on non-motor symptoms of Parkinson's disease: A subanalysis of a 1-year observational study in Japan (J-FIRST)-Reference-Cited by-同舟云学术

Influence of istradefylline on non-motor symptoms of Parkinson's disease: A subanalysis of a 1-year observational study in Japan (J-FIRST)

Published:2021-10 Issue: Volume:91 Page:115-120
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Shimo Yasushi,Maeda Tetsuya^ORCID,Chiu Shih-Wei,Yamaguchi Takuhiro,Kashihara Kenichi^ORCID,Tsuboi Yoshio,Nomoto Masahiro,Hattori Nobutaka,Watanabe Hirohisa,Saiki Hidemoto

Publisher

Elsevier BV

Subject

Clinical Neurology,Geriatrics and Gerontology,Neurology

Reference33 articles.

1. Progress toward an integrated understanding of Parkinson's disease;Rousseaux;F1000Res,2017

2. The Parkinson pandemic—a call to action;Dorsey;JAMA Neurol,2018

3. Levodopa in the treatment of Parkinson's disease: current status and new developments;Salat;J. Parkinsons Dis.,2013

4. Parkinson's disease: the non-motor issues;Chaudhuri;Park. Relat. Disord.,2011

5. Istradefylline: first global approval;Dungo;Drugs,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BBPT attenuated 6-OHDA-induced toxicity by modulating oxidative stress, apoptotic, and inflammatory proteins in primary neurons and rat models of Parkinson's disease;NeuroToxicology;2024-12

2. Research Progress in Competitive Purine Antagonists;Current Medicinal Chemistry;2023-10

3. Risk factors for developing dyskinesia among Parkinson's disease patients with wearing-off: J-FIRST;Journal of the Neurological Sciences;2023-05

4. Adenosinergic Pathway in Parkinson’s Disease: Recent Advances and Therapeutic Perspective;Molecular Neurobiology;2023-02-14

5. Istradefylline for OFF Episodes in Parkinson’s Disease: A US Perspective of Common Clinical Scenarios;Degenerative Neurological and Neuromuscular Disease;2022-07